Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- In children with high-risk neuroblastoma, how high-dose chemotherapy plus autologous hematopoietic stem cell rescue compare with conventional chemotherapy?
- Is there an association between platinum‐based chemotherapy and hearing loss in children with cancer?
Use of this content is subject to our disclaimer